Last reviewed · How we verify

NCT06271915

Role of Cervical Spine Mobilization on Lateral Epicondylitis

Recruiting now NA Last updated 21 August 2024
What this trial tests

NA trial testing SNAGs - eccentric exercise in Lateral Epicondylitis in 60 participants. Currently enrolling.

Timeline
15 February 2024
Primary endpoint
15 September 2024
15 December 2024

Quick facts

Lead sponsorCairo University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment60
Start date15 February 2024
Primary completion15 September 2024
Estimated completion15 December 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 30 to 50, any sex, with Lateral Epicondylitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study's primary goal is to examine the effectiveness of Mulligan's technique in reducing hyperalgesia in lateral epicondylitis, focusing on cervical spine, while also investigating its influence on central sensitization in relation to lateral epicondylitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lateral Epicondylitis

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06271915.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing